A randomized, double‐blind clinical trial to evaluate the efficacy and safety of a fixed‐dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension

This multicenter, randomized, double‐blind, parallel‐group phase III clinical trial aimed to investigate the efficacy and safety of a rosuvastatin + amlodipine combination compared with that of rosuvastatin or amlodipine monotherapy in hypertensive patients with dyslipidemia. A total of 106 patients...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Hypertens (Greenwich)
Auteurs principaux: Kim, Woohyeun, Chang, Kiyuk, Cho, Eun Joo, Ahn, Jeong‐Cheon, Yu, Cheol Woong, Cho, Kyoung‐Im, Kim, Yong‐Jin, Kang, Duk‐Hyun, Kim, Seok‐Yeon, Lee, Sang‐Hak, Kim, Ung, Kim, Shin‐Jae, Ahn, Young Keun, Lee, Chang Hoon, Shin, Jin Ho, Kim, Mikyung, Park, Chang Gyu
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029832/
https://ncbi.nlm.nih.gov/pubmed/32003938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13774
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires